News

The agreement encompasses development and commercial milestones for the products, which could amount to up to $180m.
Industry stakeholders have urged the European Medicines Agency to sharpen its guidance on decentralized clinical trials, ...
The Committee for Medicinal Products for Human Use (CHMP) has recommended that Imfinzi be used in combination with ...
Robert F Kennedy Jr revoked CDC’s COVID-19 vaccine advice for children and pregnant women, causing expert confusion.
LLY to acquire SiteOne for up to $1 billion. GSK's antibiotic study ends early for efficacy. MRNA loses H5 flu vaccine ...
NurExone expects to initiate a Phase 1/2a clinical trial in 2026 (" 2026 SCI Trial ”) marking a major milestone in the advancement of regenerative therapies for central nervous system injuries.
Explore the evolving landscape of cell and gene therapies (CGTs) in gastroenterology. Key therapies include Anterogen's Cupistem and Takeda's Alofisel, the latter recently withdrawn by EMA. Understand ...
The global ATMPs Consulting Market is expected to witness a healthy and a double-digit growth rate by 2027. The key factors ...
Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...
Mushroom coffee combines coffee with mushroom powders like lion's mane, reishi, chaga, shiitake, or maitake, and can contain ...
Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...
Ever had someone tell you that you need to “detox” your cortisol? Here’s a reality check: your body already comes equipped ...